Welcome to Arroyo BioSciences, LLC.

Arroyo BioSciences, LLC is discovering new drugs for the treatment of chronic inflammatory diseases characterized by fibrosis. This family of debilitating diseases strikes major organs and is often poorly diagnosed and treated.

Arroyo’s lead compound, AB22, has been granted orphan drug designation for the treatment of Idiopathic Pulmonary Fibrosis by the Office of Orphan Products Development of the Food and Drug Administration.


© Copyright 2018 Arroyo BioSciences, Silver Spring, MD - All Rights Reserved
Web site designed and maintained by Sereni Web Design